Anna M. Kauppi

698 total citations
11 papers, 578 citations indexed

About

Anna M. Kauppi is a scholar working on Genetics, Molecular Biology and Ecology, Evolution, Behavior and Systematics. According to data from OpenAlex, Anna M. Kauppi has authored 11 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 4 papers in Molecular Biology and 3 papers in Ecology, Evolution, Behavior and Systematics. Recurrent topics in Anna M. Kauppi's work include Yersinia bacterium, plague, ectoparasites research (6 papers), Botanical Research and Chemistry (3 papers) and COVID-19 and Mental Health (2 papers). Anna M. Kauppi is often cited by papers focused on Yersinia bacterium, plague, ectoparasites research (6 papers), Botanical Research and Chemistry (3 papers) and COVID-19 and Mental Health (2 papers). Anna M. Kauppi collaborates with scholars based in Sweden. Anna M. Kauppi's co-authors include Mikael Elofsson, Roland Nordfelth, Hans Wolf‐Watz, Hanna Uvell, Anna Linusson, Markus K. Dahlgren, Ing‐Marie Olsson, Alicia Edin, Åsa Gylfe and Anders Sjöstedt and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and Infection and Immunity.

In The Last Decade

Anna M. Kauppi

11 papers receiving 547 citations

Peers

Anna M. Kauppi

MB

GENET

ENDOC

MM

MICRO

Charlotta Sundin Sweden

Gerd Prehna United States

Heather B. Felise United States

Olga V. Bystrova Russia

David Sychantha Canada

Ramachandran Sarojini Santhosh India

Ahmed El Zoeiby Canada

Amy L. Bottomley Australia

Joanna Radziejewska‐Lebrecht Poland

Anna N. Kondakova Russia

Charlotta Sundin Sweden

Anna M. Kauppi

404 ×2.0

MB

355 ×1.9

GENET

283 ×2.0

ENDOC

307 ×2.2

MM

189 ×2.0

MICRO

Citations per year, relative to Anna M. Kauppi Anna M. Kauppi (= 1×) peers Charlotta Sundin

Countries citing papers authored by Anna M. Kauppi

Since Specialization

Citations

This map shows the geographic impact of Anna M. Kauppi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna M. Kauppi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna M. Kauppi more than expected).

Fields of papers citing papers by Anna M. Kauppi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna M. Kauppi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna M. Kauppi. The network helps show where Anna M. Kauppi may publish in the future.

Co-authorship network of co-authors of Anna M. Kauppi

This figure shows the co-authorship network connecting the top 25 collaborators of Anna M. Kauppi. A scholar is included among the top collaborators of Anna M. Kauppi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna M. Kauppi. Anna M. Kauppi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Edin, Alicia, Staffan Tevell, Anders Magnuson, et al.. (2023). High prevalence of persistent symptoms and reduced health-related quality of life 6 months after COVID-19. Frontiers in Public Health. 11. 9 indexed citations

2.

Edin, Alicia, Staffan Tevell, Anna M. Kauppi, et al.. (2022). High Prevalence of Persistent Symptoms and Reduced Health-Related Quality of Life 6 Months after COVID-19. SSRN Electronic Journal. 2 indexed citations

3.

Müller, D, Anna M. Kauppi, Alicia Edin, et al.. (2019). Phospholipid levels in blood during community-acquired pneumonia. PLoS ONE. 14(5). e0216379–e0216379. 15 indexed citations

4.

Kauppi, Anna M., Alicia Edin, Ingrid Ziegler, et al.. (2016). Metabolites in Blood for Prediction of Bacteremic Sepsis in the Emergency Room. PLoS ONE. 11(1). e0147670–e0147670. 36 indexed citations

5.

Kauppi, Anna M., et al.. (2007). Inhibitors of type III secretion in Yersinia: Design, synthesis and multivariate QSAR of 2-arylsulfonylamino-benzanilides. Bioorganic & Medicinal Chemistry. 15(22). 6994–7011. 25 indexed citations

6.

Dahlgren, Markus K., Anna M. Kauppi, Ing‐Marie Olsson, Anna Linusson, & Mikael Elofsson. (2007). Design, Synthesis, and Multivariate Quantitative Structure−Activity Relationship of SalicylanilidesPotent Inhibitors of Type III Secretion inYersinia. Journal of Medicinal Chemistry. 50(24). 6177–6188. 60 indexed citations

7.

Kauppi, Anna M., et al.. (2006). Salicylanilides are Potent Inhibitors of Type III Secretion in Yersinia. Kluwer Academic Publishers eBooks. 529. 97–100. 25 indexed citations

8.

Kauppi, Anna M.. (2006). CHEMICAL ATTENUATION OF BACTERIAL VIRULENCE: SMALL MOLECULE INHIBITORS OF TYPE III SECRETION. KTH Publication Database DiVA (KTH Royal Institute of Technology). 2 indexed citations

9.

Nordfelth, Roland, et al.. (2005). Small-Molecule Inhibitors Specifically Targeting Type III Secretion. Infection and Immunity. 73(5). 3104–3114. 184 indexed citations

10.

Kauppi, Anna M., Roland Nordfelth, Hanna Uvell, Hans Wolf‐Watz, & Mikael Elofsson. (2003). Targeting Bacterial Virulence. Chemistry & Biology. 10(3). 241–249. 195 indexed citations

11.

Wang, Xiaoyang, Anna M. Kauppi, Roger Olsson, & Fredrik Almqvist. (2003). Efficient Solution‐Phase Parallel Synthesis of 4‐Substituted N‐Protected Piperidines. European Journal of Organic Chemistry. 2003(23). 4586–4592. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact